Similar articles

• Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.

  van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J. van der Stoep D, et al. J Rheumatol. 2009 Dec;36(12):2847-8. doi: 10.3899/jrheum.090307. J Rheumatol. 2009. PMID: 19966199 No abstract available.
• Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases.

  Toussirot E, Pertuiset E, Kantelip B, Wendling D. Toussirot E, et al. Clin Exp Rheumatol. 2008 May-Jun;26(3):471-5. Clin Exp Rheumatol. 2008. PMID: 18578973 Review.
• Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.

  Izzi S, Francesconi F, Visca P, Altieri A, De Mutiis C, Trevisan G, Bonifati C. Izzi S, et al. Dermatol Online J. 2010 May 15;16(5):16. Dermatol Online J. 2010. PMID: 20492833
• [Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review].

  Scailteux LM, Guedes C, Polard E, Perdriger A. Scailteux LM, et al. Presse Med. 2015 Jan;44(1):4-10. doi: 10.1016/j.lpm.2014.06.028. Epub 2014 Dec 19. Presse Med. 2015. PMID: 25534463 Review. French.
• Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review.

  Massara A, Cavazzini L, La Corte R, Trotta F. Massara A, et al. Semin Arthritis Rheum. 2010 Feb;39(4):313-9. doi: 10.1016/j.semarthrit.2008.11.003. Epub 2009 Jan 15. Semin Arthritis Rheum. 2010. PMID: 19147181 Review.